Klebsiella pneumoniae bacteremia and renosplenic abscesses without intestinal symptoms as the initial manifestations of non-steroidal anti-inflammatory drug-induced colitis: a rare case report
© Huang et al.; licensee BioMed Central Ltd. 2013
Received: 26 April 2013
Accepted: 20 September 2013
Published: 22 September 2013
Non-steroidal anti-inflammatory drugs (NSAIDs), the most widely prescribed drugs in the world, can cause gastrointestinal damage, including colitis. However, the prevalence of NSAID-induced colitis is unknown because the disease is often asymptomatic.
We report the case of a 64-year-old female patient with a history of long-term NSAID use, who was hospitalized with septic shock caused by Klebsiella pneumoniae bacteremia. Computed tomography revealed multiple renal and splenic abscesses with diffuse colon wall thickening. A colonoscopy confirmed colitis with diffuse ulcers. NSAIDs were discontinued after this hospitalization. The abscesses improved after antibiotic treatment. A short course of balsalazide treatment was given under the suspicion of ulcerative colitis. Balsalazide was discontinued four months later due to a non-compatible clinical course. A follow-up colonoscopy two years later revealed a normal colon mucosa, and NSAID-induced colitis was diagnosed.
This is the first reported case of combined bacterial splenic and renal abscesses without intestinal manifestations as the initial presentation of NSAID-induced colitis. In contrast to cases of K. pneumoniae bacteremia with primary liver abscesses in patients with diabetes mellitus in Taiwan, we presented the first case with abscesses caused by community-acquired K. pneumoniae in the kidneys and spleen without liver invasion. In conclusion, our case report alerts clinicians to the possibility that K. pneumoniae bacteremia combined with multiple abscesses can be associated with severe NSAID-induced colitis.
KeywordsNon-steroidal anti-inflammatory drugs Colitis Bacteremia Klebsiella pneumoniae Renosplenic abscesses
Non-steroidal anti-inflammatory drugs (NSAIDs), despite their well-known adverse effects on the gastrointestinal (GI) tract, are widely prescribed worldwide. NSAIDs damage different regions of the GI tract, including the distal small bowel and colon can be the target of NSAIDs. A study using fecal calprotectin (a non-degraded neutrophil cytosolic protein) to diagnose NSAID enteropathy found that the prevalence of NSAID enteropathy was around 44% . Studies evaluating the colonic side effects of NSAIDs have suggested that NSAID-induced colitis is common; however, symptomatic NSAID-induced colitis is rare [2, 3]. People taking NSAIDs are two to five times more likely to develop colonic inflammation than the general population. NSAIDs affect the large intestine by causing colonic ulceration and stricture formation. Approximately 10% of newly diagnosed colitis cases may be related to NSAID administration [4, 5]. However, the prevalence of NSAID-induced colitis is unknown because the disease is often asymptomatic.
NSAID-induced colitis usually has nonspecific histological findings. The diagnosis of NSAID-induced colonic ulceration has been made based on a history of NSAID use and the exclusion of other causes . The temporal relationship between NSAID use and symptoms that resolve after cessation confirm the diagnosis of NSAID-induced colitis.
Intra-abdominal abscesses as the initial presentation of NSAID-induced colitis has not been reported previously. Herein, we report the unusual case of a patient with renal and splenic abscesses but without intestinal symptom as the initial manifestations of NSAID-induced colitis.
A 64-year-old Taiwanese woman presented with a history of well-controlled type 2 diabetes mellitus and hypertension. She had been self-treating regularly with NSAIDs from pharmacy (diclofenac, 50 mg three times daily) for more than two years because of chronic low back pain caused by intervertebral disc herniation. General malaise, poor appetite, intermittent postprandial nausea, urinary urgency and frequency were present one month before admission. She visited local clinics and received no specific diagnosis. Due to progressive shortness of breath and drowsiness for one week, she was sent to a medical center. She appeared acutely ill but afebrile, with a blood pressure of 74/34 mmHg, a pulse rate of 86/min, a respiratory rate of 22/min, and an oxygen saturation level of 93% in ambient air. Physical examination revealed no specific local findings. A blood assay revealed the following findings: leukocyte count, 44,400/μL with 85% neutrophils; hemoglobin, 12.3 g/dL; platelet count, 466, 000/μL; C-reactive protein, 235.76 mg/L; total bilirubin, 1.17 mg/dL; direct bilirubin, 0.17 mg/dL; aspartate aminotransferase, 38 IU/L; alanine aminotransferase, 21 IU/L; blood urea nitrogen, 96.77 mg/dL; creatinine, 7.8 mg/dL; sodium, 140 mmol/L; potassium, 8.6 mmol/L; and lactate, 20.3 mmol/L. The arterial blood gas analysis revealed severe metabolic acidosis (pH, 7.02; HCO3, 7.1 mmol/L). A chest radiograph revealed no pulmonary lesions. Urine analysis via catheterization revealed only mild hematuria.
The patient was treated in the outpatient department with 500 mg of oral cephradine, four times daily; 500 mg of metronidazole, three times daily; and balsalazide (2.25 g daily) for two months. The follow-up abdominal CT scan revealed complete resolution of the abscesses two months later, and the colonoscopy revealed multiple segmental longitudinal ulceration with skip lesions in the rectum, sigmoid, and terminal ileum. A colon biopsy showed necrotizing inflammation with the infiltration of mixed inflammatory cells ,including neutrophils, histiocytes, and lymphocytes. Moreover, focal ulcerated colonic mucosa with inflammatory infiltration was found in the edematous, fibrous lamina propria. Some distorted glands were observed, but no crypt abscesses were noted. Balsalazide was discontinued after a course of four months. She had an uneventful course in the out-patient department, and a follow-up colonoscopy two years later revealed melanosis coli and internal hemorrhoid only, without ulcers or stenosis over the entire colon.
Our case is unique due to the presentation of severe colitis without an initial manifestation of intestinal symptoms. NSAID-induced colitis was diagnosed based on the history of long-term NSAID use after excluding other etiologies. To the best of our knowledge, this is the first reported case of NSAID-induced colitis with renal and splenic abscesses caused by community-acquired K. pneumoniae without liver involvement.
K. pneumoniae, a gram-negative encapsulated aerobic bacterium, is part of the normal flora of the human mouth and intestines. Human carrier rates in the community range from 5 to 38% in the stool and from 1 to 6% in the nasopharynx [6, 7]. The infection rate is higher for individuals with impaired host defenses, such as individuals with diabetes mellitus and hepatobiliary tract disease [8, 9]. K. pneumoniae has been reported to be the most common pathogen associated with pyogenic hepatic abscesses and splenic abscesses, especially in Taiwan and countries in Eastern and Southeast Asia [10–12], and this bacterium accounts for 10–16% of cases of splenic abscess and approximately 25% of cases of renal abscess [13, 14].
Intra-abdominal abscesses have diverse symptoms. Fever and abdominal pain are the most frequent symptoms, but a few cases have vague symptoms, as in the case presented herein. Imaging analysis, including ultrasonography and computed tomography (CT), are necessary to diagnose intra-abdominal infections .
Splenic abscesses are rare, with a reported frequency of 0.14–0.7% in case reports . Chang et al. analyzed 67 splenic abscess cases which occurred over a period of 19 years and found that K. pneumoniae was the most frequently encountered pathogen in blood cultures or abscess cultures, similar to observations from other Asian countries . Ferraioli G. et al. found a different result; they observed that the most common pathogens were polymicrobial pathogens in pus cultures and Staphylococcus species in blood cultures .
The pathogenesis of intra-abdominal abscesses caused by K. pneumoniae remains unclear. One hypothesis for the pathogenesis of pyogenic intra-abdominal abscesses involves hematogenous bacterial seeding from the GI tract. An animal study demonstrated that K. pneumoniae strains with genetic regulatory networks for translocation have the ability to cross the intestinal barrier . A careful search for the source of K. pneumoniae bacteremia other than primary bacteremia should be considered, and which should include colon lesions survey . In our case, the finding of thickened colonic wall prompted us to consider the colon as the possible source of K. pneumoniae bacteremia.
Prostaglandins represent one of the most important components of mucosal defense in the colon and are involved in the maintenance of microcirculation and blood flow to modulate the mucosal immune system. NSAIDs inhibit colonic prostaglandin synthesis, leading to the development of colitis and the aggravation of preexisting intestinal diseases.
The ileocecal region is the most common site of NSAID-induced colonic injury. Pathological examination of colon specimens from patients with NSAID-induced colitis usually reveals sharply demarcated, semilunar or circumferential, superficial ulcerations with normal surrounding mucosa. There are no specific histopathological findings for NSAID-induced colitis except for the diaphragm-like stricture. Cellular infiltration into the lamina propria and epithelium may involve predominantly neutrophils or lymphocytes, depending on the chronicity of the lesion . Symptomatic patients may have watery or bloody diarrhea, weight loss, fatigue, abdominal pain, anorexia, iron-deficiency anemia, and hypoalbuminemia.
There have been no studies to determine the risk of colitis related to different types of NSAIDs; however, many reports have stated that diclofenac, mefenemic acid, piroxicam, and ibuprofen could cause colorectal ulcers or colitis [4, 20–22]. According to one case-controlled study, the long-term use of NSAIDs increased the risk of colonic mucosal lesions, suggesting that NSAIDs may contribute to the pathogenesis of colonic ulcers or colitis . In addition, naproxen has been implicated in eosinophilic colitis , and diclofenac may be associated with pseudomembranous colitis .
In this case, the colonoscopy findings and pathological findings were not able to determine the etiology of the colitis. Due to evidence of a possible association between the use of NSAIDs and the exacerbation or relapse of inflammatory bowel diseases [26, 27], NSAID-exacerbated inflammatory bowel disease was initially suspected. This patient was initially treated with balsalazide, but she became stable despite the discontinuation of balsalazide.
The discontinuation of NSAIDs is the cornerstone of the treatment of NSAID-induced colitis. Symptoms usually resolve within days to weeks of the withdrawal of NSAIDs, with the restoration of normal histology. Our patient received a colonoscopy two years later that revealed complete restoration of the colon mucosa; thus, this patient was diagnosed with NSAID-induced colitis.
We present a unique case of NSAID-induced colitis without any GI symptoms at initial presentation, that was associated with septic shock caused by K. pneumoniae bacteremia with multiple renal and splenic abscesses. The colitis was found incidentally by CT and then identified as NSAID-induced colitis. This is also the first reported case of disseminated abscess formation caused by community-acquired K. pneumoniae in the kidneys and spleen without liver involvement in an NSAID-induced colitis patient.
This case is a reminder that hematogenous intra-abdominal abscesses caused by K. pneumoniae necessitate a thorough investigation of the GI tract. Assessing the presence of colitis should be considered even in the absence of preceding gastrointestinal symptoms, especially for those who have previously used NSAIDs.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Non-steroidal anti-inflammatory drugs
- Deshpande V, Hsu M, Kumarasinghe MP, Lauwers GY: The clinical significance of incidental chronic colitis: a study of 17 cases. Am J Surg Pathol. 2010, 34: 463-469. 10.1097/PAS.0b013e3181d0fd76.View ArticlePubMedGoogle Scholar
- Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M: Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol. 2001, 96: 473-480. 10.1111/j.1572-0241.2001.03530.x.View ArticlePubMedGoogle Scholar
- Puspok A, Kiener HP, Oberhuber G: Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum. 2000, 43: 685-691. 10.1007/BF02235589.View ArticlePubMedGoogle Scholar
- Tanner AR, Raghunath AS: Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion. 1988, 41: 116-120. 10.1159/000199740.View ArticlePubMedGoogle Scholar
- Katsinelos P, Christodoulou K, Pilpilidis I, Xiarchos P, Papagiannis A, Dimiropoulos S, Amperiadis P, Vasiliadis T, Tarpagos A, Katsos I, Eugenidis N: Colopathy associated with the systemic use of nonsteroidal antiinflammatory medications. An underestimated entity. Hepatogastroenterology. 2002, 49: 345-348.PubMedGoogle Scholar
- Fung CP, Lin YT, Lin JC, Chen TL, Yeh KM, Chang FY, Chuang HC, Wu HS, Tseng CP, Siu LK: Klebsiella pneumoniae in gastrointestinal tract and pyogenic liver abscess. Emerg Infect Dis. 2012, 18: 1322-1325.View ArticlePubMedPubMed CentralGoogle Scholar
- Podschun R, Ullmann U: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998, 11: 589-603.PubMedPubMed CentralGoogle Scholar
- Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW: Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci. 2006, 21: 816-822. 10.3346/jkms.2006.21.5.816.View ArticlePubMedPubMed CentralGoogle Scholar
- Wu HS, Wang FD, Tseng CP, Wu TH, Lin YT, Fung CP: Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect. 2012, 64: 162-168. 10.1016/j.jinf.2011.11.005.View ArticlePubMedGoogle Scholar
- Lederman ER, Crum NF: Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005, 100: 322-331. 10.1111/j.1572-0241.2005.40310.x.View ArticlePubMedGoogle Scholar
- Chang KC, Chuah SK, Changchien CS, Tsai TL, Lu SN, Chiu YC, Chen YS, Wang CC, Lin JW, Lee CM, Hu TH: Clinical characteristics and prognostic factors of splenic abscess: a review of 67 cases in a single medical center of Taiwan. World J Gastroenterol. 2006, 12: 460-464.View ArticlePubMedPubMed CentralGoogle Scholar
- Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY: Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012, 12: 881-887. 10.1016/S1473-3099(12)70205-0.View ArticlePubMedGoogle Scholar
- Lee CH, Leu HS, Hu TH, Liu JW: Splenic abscess in southern Taiwan. J Microbiol Immunol Infect. 2004, 37: 39-44.PubMedGoogle Scholar
- Lee BE, Seol HY, Kim TK, Seong EY, Song SH, Lee DW, Lee SB, Kwak IS: Recent clinical overview of renal and perirenal abscesses in 56 consecutive cases. Korean J Intern Med. 2008, 23: 140-148. 10.3904/kjim.2008.23.3.140.View ArticlePubMedPubMed CentralGoogle Scholar
- Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, et al: Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010, 50: 133-164. 10.1086/649554.View ArticlePubMedGoogle Scholar
- Ferraioli G, Brunetti E, Gulizia R, Mariani G, Marone P, Filice C: Management of splenic abscess: report on 16 cases from a single center. Int J Infect Dis. 2009, 13: 524-530. 10.1016/j.ijid.2008.08.024.View ArticlePubMedGoogle Scholar
- Tu YC, Lu MC, Chiang MK, Huang SP, Peng HL, Chang HY, Jan MS, Lai YC: Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun. 2009, 77: 2657-2671. 10.1128/IAI.01523-08.View ArticlePubMedPubMed CentralGoogle Scholar
- Jeong SW, Jang JY, Lee TH, Kim HG, Hong SW, Park SH, Kim SG, Cheon YK, Kim YS, Cho YD, et al: Cryptogenic pyogenic liver abscess as the herald of colon cancer. J Gastroenterol Hepatol. 2012, 27: 248-255. 10.1111/j.1440-1746.2011.06851.x.View ArticlePubMedGoogle Scholar
- Goldstein NS, Cinenza AN: The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am J Clin Pathol. 1998, 110: 622-628.View ArticlePubMedGoogle Scholar
- Ravi S, Keat A, Keat E: Colitis caused by non-steroidal anti-inflammatory drugs. Postgrad Med J. 1986, 62: 773-776. 10.1136/pgmj.62.730.773.View ArticlePubMedPubMed CentralGoogle Scholar
- Witham R: Voltaren (diclofenac sodium)-induced ileocolitis. Am J Gastroenterol. 1991, 86: 246-247.PubMedGoogle Scholar
- Pan YS, Chen LT, Tseng CA, Su YC, Jan CM, Wang WM, Tsai KB: Clinical and endoscopic features of non-steroidal anti-inflammatory drug-induced colorectal ulcerations. J Formos Med Assoc. 2005, 104: 804-810.PubMedGoogle Scholar
- Shibuya T, Ohkusa T, Yokoyama T, Harada A, Beppu K, Sakamoto N, Osada T, Nagahara A, Terai T, Otaka M: Colonic mucosal lesions associated with long‒term or short‒term administration of nonsteroidal anti‒inflammatory drugs. Colorectal Dis. 2010, 12: 1113-1121. 10.1111/j.1463-1318.2009.01948.x.View ArticlePubMedGoogle Scholar
- Alfadda AA, Storr MA, Shaffer EA: Eosinophilic colitis: epidemiology, clinical features, and current management. Therap Adv Gastroenterol. 2011, 4: 301-309. 10.1177/1756283X10392443.View ArticlePubMedPubMed CentralGoogle Scholar
- Gentric A, Pennec Y: Diclofenac-induced pseudomembranous colitis. Lancet. 1992, 340: 126-127.View ArticlePubMedGoogle Scholar
- Ballinger A: Adverse effects of nonsteroidal anti-inflammatory drugs on the colon. Curr Gastroenterol Rep. 2008, 10: 485-489. 10.1007/s11894-008-0089-5.View ArticlePubMedGoogle Scholar
- Kefalakes H, Stylianides TJ, Amanakis G, Kolios G: Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?. Eur J Clin Pharmacol. 2009, 65: 963-970. 10.1007/s00228-009-0719-3.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/13/139/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.